---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-379423"
form_type: "8-K"
ticker: "ALLO"
cik: "0001737287"
company_name: "Allogene Therapeutics, Inc."
filed_at: "2026-09-02T12:35:05+00:00"
generated_at: "2026-09-02T12:36:08.195517+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Allogene CFO Geoffrey Parker to retire effective Nov 6, 2026

## Summary
- Geoffrey Parker, EVP and CFO, notified company of retirement on Aug 31, 2026.
- Retirement effective November 6, 2026; he will depart in all capacities.
- No successor named in the filing; company has not announced a replacement.
- Parker served as principal financial officer; transition period of ~2 months.

## SEC filing metadata
- accession: 0001193125-26-379423
- form_type: 8-K
- ticker: ALLO
- cik: 0001737287
- company_name: Allogene Therapeutics, Inc.
- filed_at: 2026-09-02T12:35:05+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737287/000119312526379423/0001193125-26-379423-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737287/000119312526379423/d522964d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-379423
- JSON: https://secwatch.observer/filing/0001193125-26-379423.json
- Plain text: https://secwatch.observer/filing/0001193125-26-379423.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.